112 related articles for article (PubMed ID: 15968385)
21. Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor.
Fan J; Kapus A; Li YH; Rizoli S; Marshall JC; Rotstein OD
Am J Respir Cell Mol Biol; 2000 Apr; 22(4):412-21. PubMed ID: 10745022
[TBL] [Abstract][Full Text] [Related]
22. Rapid lung cytokine accumulation and neutrophil recruitment after lipopolysaccharide inhalation by cigarette smokers and nonsmokers.
Wesselius LJ; Nelson ME; Bailey K; O'Brien-Ladner AR
J Lab Clin Med; 1997 Jan; 129(1):106-14. PubMed ID: 9011586
[TBL] [Abstract][Full Text] [Related]
23. Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection.
Choi G; Schultz MJ; van Till JW; Bresser P; van der Zee JS; Boermeester MA; Levi M; van der Poll T
Eur Respir J; 2004 Nov; 24(5):786-9. PubMed ID: 15516673
[TBL] [Abstract][Full Text] [Related]
24. The abnormalities of coagulation and fibrinolysis in acute lung injury caused by gas explosion.
Tian LQ; Guo ZH; Meng WZ; Li L; Zhang Y; Yin XH; Lai F; Li YY; Feng LL; Shen FF; Sun ZZ; Yao SQ; Wu WD; Weng XG; Ren WJ
Kaohsiung J Med Sci; 2020 Nov; 36(11):929-936. PubMed ID: 32643870
[TBL] [Abstract][Full Text] [Related]
25. Extravascular coagulation and fibrinolysis in murine lung inflammation induced by the mycobacterial cord factor trehalose-6,6'-dimycolate.
Perez RL; Roman J; Staton GW; Hunter RL
Am J Respir Crit Care Med; 1994 Feb; 149(2 Pt 1):510-8. PubMed ID: 8306054
[TBL] [Abstract][Full Text] [Related]
26. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans.
van der Poll T; Coyle SM; Levi M; Jansen PM; Dentener M; Barbosa K; Buurman WA; Hack CE; ten Cate JW; Agosti JM; Lowry SF
Blood; 1997 May; 89(10):3727-34. PubMed ID: 9160678
[TBL] [Abstract][Full Text] [Related]
27. Early procoagulant shift in the bronchoalveolar compartment of patients with secondary peritonitis.
van Till JW; Levi M; Bresser P; Schultz MJ; Gouma DJ; Boermeester MA
J Infect Dis; 2006 Nov; 194(9):1331-9. PubMed ID: 17041861
[TBL] [Abstract][Full Text] [Related]
28. Reactive oxygen species by isoflurane mediates inhibition of nuclear factor κB activation in lipopolysaccharide-induced acute inflammation of the lung.
Chung IS; Kim JA; Kim JA; Choi HS; Lee JJ; Yang M; Ahn HJ; Lee SM
Anesth Analg; 2013 Feb; 116(2):327-35. PubMed ID: 23302986
[TBL] [Abstract][Full Text] [Related]
29. Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia.
Rijneveld AW; Weijer S; Bresser P; Florquin S; Vlasuk GP; Rote WE; Spek CA; Reitsma PH; van der Zee JS; Levi M; van der Poll T
Crit Care Med; 2006 Jun; 34(6):1725-30. PubMed ID: 16625114
[TBL] [Abstract][Full Text] [Related]
30. Pretreatment with olprinone hydrochloride, a phosphodiesterase III inhibitor, attenuates lipopolysaccharide-induced lung injury via an anti-inflammatory effect.
Koike T; Nadeen Qutab M; Tsuchida M; Takekubo M; Saito M; Hayashi J
Pulm Pharmacol Ther; 2008; 21(1):166-71. PubMed ID: 17434327
[TBL] [Abstract][Full Text] [Related]
31. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.
de Jonge E; Dekkers PE; Creasey AA; Hack CE; Paulson SK; Karim A; Kesecioglu J; Levi M; van Deventer SJ; van Der Poll T
Blood; 2000 Feb; 95(4):1124-9. PubMed ID: 10666180
[TBL] [Abstract][Full Text] [Related]
32. Protectin D1 promotes resolution of inflammation in a murine model of lipopolysaccharide-induced acute lung injury via enhancing neutrophil apoptosis.
Li X; Li C; Liang W; Bi Y; Chen M; Dong S
Chin Med J (Engl); 2014; 127(5):810-4. PubMed ID: 24571867
[TBL] [Abstract][Full Text] [Related]
33. Taraxacum officinale protects against lipopolysaccharide-induced acute lung injury in mice.
Liu L; Xiong H; Ping J; Ju Y; Zhang X
J Ethnopharmacol; 2010 Jul; 130(2):392-7. PubMed ID: 20510343
[TBL] [Abstract][Full Text] [Related]
34. Lipopolysaccharide (LPS) inhalation in healthy subjects increases neutrophils, lymphocytes and fibronectin levels in bronchoalveolar lavage fluid.
Sandström T; Bjermer L; Rylander R
Eur Respir J; 1992 Sep; 5(8):992-6. PubMed ID: 1426208
[TBL] [Abstract][Full Text] [Related]
35. Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats.
van Westerloo DJ; Giebelen IA; Meijers JC; Daalhuisen J; de Vos AF; Levi M; van der Poll T
J Thromb Haemost; 2006 Sep; 4(9):1997-2002. PubMed ID: 16805873
[TBL] [Abstract][Full Text] [Related]
36. Inhalation of activated protein C inhibits endotoxin-induced pulmonary inflammation in mice independent of neutrophil recruitment.
Slofstra SH; Groot AP; Maris NA; Reitsma PH; Cate HT; Spek CA
Br J Pharmacol; 2006 Nov; 149(6):740-6. PubMed ID: 17016502
[TBL] [Abstract][Full Text] [Related]
37. Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans.
Verbon A; Meijers JC; Spek CA; Hack CE; Pribble JP; Turner T; Dekkers PE; Axtelle T; Levi M; van Deventer SJ; Reitsma PH; van der Poll T
J Infect Dis; 2003 Jan; 187(1):55-61. PubMed ID: 12508146
[TBL] [Abstract][Full Text] [Related]
38. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.
Pärsson H; Holmberg A; Siegbahn A; Bergqvist D
Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):186-92. PubMed ID: 14718902
[TBL] [Abstract][Full Text] [Related]
39. Nebulized Recombinant Human Tissue Factor Pathway Inhibitor Attenuates Coagulation and Exerts Modest Anti-inflammatory Effects in Rat Models of Lung Injury.
van den Boogaard FE; Hofstra JJ; Brands X; Levi MM; Roelofs JJ; Zaat SA; Van't Veer C; van der Poll T; Schultz MJ
J Aerosol Med Pulm Drug Deliv; 2017 Apr; 30(2):91-99. PubMed ID: 27977318
[TBL] [Abstract][Full Text] [Related]
40. Lipopolysaccharide-induced lung injury in mice. I. Concomitant evaluation of inflammatory cells and haemorrhagic lung damage.
Asti C; Ruggieri V; Porzio S; Chiusaroli R; Melillo G; Caselli GF
Pulm Pharmacol Ther; 2000; 13(2):61-9. PubMed ID: 10799283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
